Changes after publication

Changes after publication

February 2016: Statement 6 on the use of valproate in women of childbearing potential has been removed from this quality standard and is replaced by statement 1 in the NICE quality standard for antenatal and postnatal mental health (QS115) published February 2016. This change was made to ensure alignment with the NICE quality standard on antenatal and postnatal mental health and reflect more clearly that valproate should not be prescribed to treat mental health problems in women of childbearing potential unless in exceptional circumstances.